Showing results (21-30 of 389) with videos related to

Sort By:
Pageof 39
Therapeutic Advances in Medical Oncology|July 27, 2011
The emerging role of epidermal growth factor receptor (EGFR) inhibitors in first-line treatment for patients with advanced non-small cell lung cancer positive for EGFR mutationsIsamu Okamoto, Tetsuya Mitsudomi, Kazuhiko Nakagawa, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 2, 2008
Pharmacokinetic analysis of carboplatin and etoposide in a small cell lung cancer patient undergoing hemodialysisKen Takezawa, Isamu Okamoto, Masahiro Fukuoka, et al.
Clinical Lung Cancer|February 17, 2024
Phase II Trial of Adjuvant Atezolizumab Therapy in Elderly Patients with Completely Resected Stage II/III Non-Small Cell Lung Cancer: RELIANCE TrialTaichi Matsubara, Masafumi Yamaguchi, Mototsugu Shimokawa, et al.
Respirology Case Reports|December 4, 2023
Allergic bronchopulmonary aspergillosis manifested secondary to bacterial pleural empyemaHiromu Kawano, Keiko Kan-O, Ayaka Egashira, et al.
Cancer Management and Research|November 19, 2021
Phase II Study of Nivolumab Plus Ipilimumab with Platinum-Based Chemotherapy for Treatment-Naïve Advanced Non-Small Cell Lung Cancer with Untreated Brain Metastases: NIke Trial (LOGiK2004)Yuko Tsuchiya-Kawano, Yoshimasa Shiraishi, Fumiaki Kiyomi, et al.
BMC Cancer|August 2, 2012
Impact of treatment with bevacizumab beyond disease progression: a randomized phase II study of docetaxel with or without bevacizumab after platinum-based chemotherapy plus bevacizumab in patients with advanced nonsquamous non-small cell lung cancer (WJOG 5910L)Masayuki Takeda, Isamu Okamoto, Takeharu Yamanaka, et al.
Clinical Lung Cancer|October 31, 2012
Postprogression survival in patients with advanced non-small-cell lung cancer who receive second-line or third-line chemotherapyHidetoshi Hayashi, Isamu Okamoto, Masataka Taguri, et al.
Oncology Letters|December 2, 2014
Multiple regulatory mechanisms of hepatocyte growth factor expression in malignant cells with a short poly(dA) sequence in the HGF gene promoterKazuko Sakai, Masayuki Takeda, Isamu Okamoto, et al.
FEBS Letters|November 26, 2008
The anti-EGFR monoclonal antibody blocks cisplatin-induced activation of EGFR signaling mediated by HB-EGFTakeshi Yoshida, Isamu Okamoto, Tsutomu Iwasa, et al.
Oncotargets and Therapy|March 14, 2014
Development of anaplastic lymphoma kinase (ALK) inhibitors and molecular diagnosis in ALK rearrangement-positive lung cancerEiji Iwama, Isamu Okamoto, Taishi Harada, et al.
Pageof 39